Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ElMindA logo — company profile

ElMindA

Founded 2006 11-50 employees Grant Total: $48.20M Biotechnology, Health Care +1

General Information

Company Name ElMindA
Founded Year 2006
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ElMindA. To contact ElMindA, visit elminda.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ElMindA compare?

A PDF of ElMindA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ElMindA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ElMindA

ElMindA, founded in 2006, is a biotechnology and medical devices startup with a focus on revolutionizing the management of brain disorders and injuries. The company's BNA™ technology platform, supported by a €2.80M grant investment from the European Commission in March 31, 2019, is designed to provide a high-resolution visualization and evaluation of the complex neurophysiological connections in the human brain. This technology captures detailed information on the composition, connectivity, synchronization, and operation of brain networks, aiming to bring advanced neuroscience into everyday clinical practice. ElMindA's innovative approach holds significant potential for transforming the diagnosis and treatment of neurological conditions.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €2.80M 1
European Commission
31 Mar 2019
Series C $28.00M 6
OurCrowd WR Hambrecht + Co QB1 Ventures
OurCrowd, WR Hambrecht + Co +4
16 Nov 2015
Funding Round $13.80M -
01 Dec 2011
Venture Round $3.60M -
01 Jun 2006

FAQ About ElMindA

ElMindA aims to change the management of brain disorders and injuries by bringing advanced neuroscience into everyday clinical practice. ElMindA's BNA™ technology platform provides high-resolution visualization and evaluation of the complex neurophysiological connections in the human brain, capturi...
ElMindA was founded in 2006.
ElMindA operates in Biotechnology, Health Care and Medical Devices.
ElMindA has approximately 11-50 employees.
ElMindA has completed 4 funding rounds, raising a total of $48.20M. The latest funding stage is Grant.

We're actively collecting intelligence on ElMindA.

Source: BounceWatch company record for ElMindA, https://bouncewatch.com/company/elminda, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes